All In MedTech

Device Trial Radar · NCT07878312

Collagen Scaffold Bioaugmentation for ATFL Repair in Chronic Ankle Instability

Superior Efficacy of Arthroscopic Bioaugmented Anterior Talofibular Ligament Repair With a Collagen Scaffold Compared With Internal Brace Augmentation: A Single-Center Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Sep 2029

Study completion Sep 2030

Sponsor

Sponsor type
Academic, hospital or other
First posted
Oct 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, controlled clinical trial comparing two surgical techniques for the treatment of chronic ankle instability (CAI). CAI is a condition in which the outer ligaments of the ankle remain loose and the ankle continues to give way after repeated sprains, causing pain, swelling, and difficulty with sports and daily activities. About 30-40% of patients who sprain an ankle go on to develop CAI. All patients in this study receive arthroscopic repair of the anterior talofibular ligament (ATFL) - the main ligament on the outside of the ankle - together with an Internal Brace, a high-strength suture tape that provides immediate mechanical reinforcement. In the experimental group, an absorbable type I collagen scaffold (REGENETEN) is additionally wrapped onto the repair to promote the regrowth of ligament-like tissue. Patients in the control group receive the Internal Brace repair alone. Eligible patients are aged 18 to 65 with chronic lateral ankle instability that has not improved with standard non-surgical treatment and in whom the ATFL tissue is of poor quality or a previous repair has failed. Participants are randomly assigned 1:1 to one of the two groups, and treatment is assigned by a central computer-generated schedule stratified by study site. Both groups follow the same standardized surgical steps and the same post-operative rehabilitation program. The main question is whether adding the collagen scaffold leads to better ankle function and stability 12 months after surgery. Patient-reported function, pain, return to sport, MRI evidence of ligament healing, and any complications will be followed for up to 24 months.

Conditions

  • Chronic Ankle Instability
  • Ankle Sprain
  • Joint Instability

Interventions

  • Arthroscopic Anterior Talofibular Ligament RepairProcedure

    Arthroscopic examination and repair of the anterior talofibular ligament (ATFL) using the LassoLoop self-locking suture technique via standard anteromedial and anterolateral portals. The residual ligament is debrided and reattached to its anatomic footprint on the fibula.

  • Internal Brace AugmentationDevice

    Mechanical augmentation of the ATFL repair using a FiberTape high-strength suture tape anchored to the fibula with a bioabsorbable suture anchor and to the talus with a 4.75 mm SwiveLock anchor, providing immediate post-operative stability and protecting the repair during early healing. The Internal Brace system is manufactured by Arthrex.

  • REGENETEN Bioinductive Collagen ScaffoldDevice

    Intervention Description (\*) Biological augmentation using a REGENETEN bioinductive, absorbable type I collagen scaffold (Smith \& Nephew) braided onto a TigerTape suture, passed through fibular and talar bone tunnels, and fixed with 4.75 mm SwiveLock anchors. The scaffold has a porous microstructure and aligned fiber orientation that supports host cell migration and tissue ingrowth, gradually degrades over approximately six months, and is replaced by host tendon-/ligament-like tissue.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Karlsson-Peterson Ankle Function Score at 12 MonthsTime frame: 12 months post-operatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.